Back to top
more

Haleon PLC Sponsored ADR (HLN)

(Delayed Data from NYSE)

$8.96 USD

8.96
18,834,659

+0.09 (1.01%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $8.96 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 247)

Industry: Consumer Products - Discretionary

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

HLN vs. SYK: Which Stock Is the Better Value Option?

by Zacks Equity Research

HLN vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

Down 7.4% in 4 Weeks, Here's Why Haleon PLC Sponsored ADR (HLN) Looks Ripe for a Turnaround

by Zacks Equity Research

Haleon PLC Sponsored ADR (HLN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Kinjel Shah headshot

GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?

by Kinjel Shah

We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.

Zacks Equity Research

Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

by Zacks Equity Research

Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.

Zacks Equity Research

AHCO vs. HLN: Which Stock Is the Better Value Option?

by Zacks Equity Research

AHCO vs. HLN: Which Stock Is the Better Value Option?

Kinjel Shah headshot

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

by Kinjel Shah

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its sales and profits to improve.

Zacks Equity Research

HLN or PODD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HLN vs. PODD: Which Stock Is the Better Value Option?

Kinjel Shah headshot

GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold?

by Kinjel Shah

GSK's cheap valuation, reasonable stock price appreciation and bright growth potential indicate that investors should stay invested.

Zacks Equity Research

Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug

by Zacks Equity Research

Dr. Reddy's (RDY) is gearing up to potentially collaborate with Kainomyx to jointly develop an affordable anti-malarial drug.

Sundeep Ganoria headshot

GSK Stock Before Q2 Earnings: To Buy or Not to Buy?

by Sundeep Ganoria

We expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Trelegy Ellipta and Shingrix to drive second-quarter sales performance.